Iowa Senate Bill SSB3138

Iowa 2023-2024 Regular Session

• Introduced: 1/31/24
• Refer: 1/31/24

Caption

A bill for an act relating to the use of genetic information provided to an insurer that offers health insurance, disability insurance, life insurance, or long-term care insurance.(See SF 2360.)

Impact

The passage of SSB3138 would provide a critical framework that prevents insurers from discriminating against individuals based on their genetic information. This includes stipulations that an insurer cannot consider genetic predispositions as preexisting conditions when determining coverage or rates. This change is significant because it seeks to create a more equitable insurance environment where the rights of the insured are protected, especially for those with family histories of genetic conditions. By extending such protections, the bill aims to secure broader access to necessary insurance coverage without the fear of discrimination.

Summary

Senate Study Bill 3138 addresses the use and handling of genetic information by insurers providing health, disability, life, and long-term care insurance. The bill aims to enhance protections for individuals in regards to their genetic information, emphasizing the right to privacy and consent before such information can be disclosed by insurers. Currently, an individual's genetic data cannot be released without prior written authorization, a stipulation that this bill extends to all categories of insurance mentioned, thereby reinforcing compliance across multiple sectors of the insurance industry.

Contention

Discussions surrounding SSB3138 may involve arguments about the balance between protecting consumers' rights to privacy and the operational needs of insurance companies. Insurers may express concerns about the potential operational burdens created by the requirement for written consent for each disclosure of genetic information. Moreover, industry representatives might argue that the bill could result in increased costs or complications in underwriting practices, as they adjust to the stricter non-discrimination policies. Nonetheless, advocates of the bill argue that the long-term benefits of promoting fair access to insurance outweigh these concerns, framing the legislation as a vital step toward enhancing consumer protections in the rapidly evolving landscape of medical technology and genetic research.